SCHEMBL7870258

SCHEMBL7870258

O=[C]COC(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
IDO1 P14902 3/20 0.45
TDO2 P48775 3/20 0.45
POLB P06746 1/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TSHR P16473 3/20 0.40
HIF1A Q16665 3/20 0.40
CYP3A4 P08684 2/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
SLC22A1 O15245 1/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7286111 0.79 MEN1 (0.51) LMNASMN1; SMN2MEN1KMT2ATSHR
SCHEMBL4667552 0.76 IDO1 (0.54) LMNASMN1; SMN2IDO1TDO2POLB
SCHEMBL7429799 0.72 IDO1 (0.50) LMNASMN1; SMN2IDO1TDO2POLB
SCHEMBL5546047 0.72 IDO1 (0.50) LMNASMN1; SMN2IDO1TDO2TSHR
Hydrochloric Acid SCHEMBL9714844 0.71 IDO1 (0.54) LMNASMN1; SMN2IDO1TDO2POLB
SCHEMBL7583717 0.71 LMNA (0.51) LMNASMN1; SMN2IDO1TDO2POLB
SCHEMBL7876579 0.71 LMNA (0.47) LMNASMN1; SMN2IDO1TDO2POLB
SCHEMBL5190981 0.69 CYP3A4 (0.64) LMNASMN1; SMN2IDO1TDO2TSHR
SCHEMBL4669314 0.69 CYP3A4 (0.64) LMNASMN1; SMN2IDO1TDO2TSHR
SCHEMBL423397 0.69 LMNA (0.54) LMNASMN1; SMN2IDO1TDO2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313094-B1 COMPOSITION FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS REPLICATION JAPAN ENERGY CORPORATION (JP) 2001-11-06 US disclosed
EP-0490667-B1 HIV protease inhibitors JAPAN ENERGY CORP (JP) 1999-06-09 EP disclosed
EP-0490667-A2 HIV protease inhibitors JAPAN ENERGY CORPORATION (JP) 1992-06-17 EP disclosed